Want to see GTBP full AI Analyst Report?
GT Biopharma (GTBP) Ownership Overview
The ownership structure of GT Biopharma (GTBP) stock is a mix of institutional, retail, and individual investors. , and 52.57% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 451,875 | Institution | 25.04% | 3,890,644 | |
| 376,399 | Institution | 20.86% | 3,240,795 | |
| 27,607 | Institution | 1.53% | 237,696 | |
| 23,400 | Institution | 1.30% | 201,474 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 451,875 | Institution | 25.04% | 3,890,644 | |
| 27,607 | Institution | 1.53% | 237,696 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 376,399 | Institution | 20.86% | 110,473 |
FAQ
Who Owns GT Biopharma (GTBP)?
Currently, no data Available
What percentage of GT Biopharma (GTBP) stock is held by institutional investors?
Currently, no data Available
What percentage of GT Biopharma (GTBP) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.57% of GT Biopharma (GTBP) stock is held by retail investors.
Who owns the most shares of GT Biopharma (GTBP)?
VANGUARD INDEX FUNDS owns the most shares of GT Biopharma (GTBP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.